Community/Retail

Avella Specialty Pharmacy announced today that it has been selected by pharmaceutical manufacturer AbbVie to dispense Venclexta (venetoclax), the first therapy in its class to win FDA approval.

NaviHealth, a Cardinal Health company, has entered into an agreement to acquire Curaspan Health Group, a privately held leading provider of care transition tools for hospitals and post-acute healthcare providers.

Aurobindo Pharma Limited has received final approval from the FDA to launch valganciclovir tablets USP, 450 mg, which are therapeutically equivalent to Hoofman-LaRoche's Valcyte.